Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Helius Medical Technologies Inc (HSDT)
Helius Medical Technologies Inc (HSDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,065
  • Shares Outstanding, K 708
  • Annual Sales, $ 790 K
  • Annual Income, $ -14,070 K
  • 60-Month Beta 1.48
  • Price/Sales 4.15
  • Price/Cash Flow N/A
  • Price/Book 1.31
Trade HSDT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -8.50
  • Growth Rate Est. (year over year) +11,852.94%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.70 +0.70%
on 02/23/24
9.50 -39.58%
on 02/06/24
-1.48 (-20.45%)
since 01/23/24
3-Month
5.70 +0.70%
on 02/23/24
9.50 -39.58%
on 02/06/24
-0.76 (-11.69%)
since 11/22/23
52-Week
5.69 +0.88%
on 08/25/23
16.25 -64.68%
on 03/01/23
-8.21 (-58.85%)
since 02/23/23

Most Recent Stories

More News
Helius Medical Technologies to Present at LD Micro Invitational XIII 2023

Newtown, Pennsylvania--(Newsfile Corp. - May 25, 2023) - Helius Medical Technologies, Inc. (NASDAQ: HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation...

HSDT : 5.74 (-1.03%)
Silk Road Medical (SILK) Reports Q1 Loss, Lags Revenue Estimates

Silk Road Medical (SILK) delivered earnings and revenue surprises of -10.26% and 1.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

SILK : 17.00 (-1.68%)
HSDT : 5.74 (-1.03%)
Inogen (INGN) Reports Q1 Loss, Lags Revenue Estimates

Inogen (INGN) delivered earnings and revenue surprises of 18.18% and 2.80%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

INGN : 9.19 (-1.92%)
HSDT : 5.74 (-1.03%)
5 Winning Stocks Backed by the Overlooked Rising P/E Trick

Want to try an out-of-the-box approach? Tap AMC Entertainment (AMC), Live Nation Entertainment (LYV), CuriosityStream (CURI), Helius Medical Technologies (HSDT) and Vir Biotechnology (VIR).

LYV : 95.32 (+1.96%)
AMC : 4.44 (+0.45%)
HSDT : 5.74 (-1.03%)
VIR : 11.53 (+11.94%)
CURI : 0.4529 (-1.56%)
Helius Medical Technologies, Inc. (HSDT) Moves to Buy: Rationale Behind the Upgrade

Helius Medical Technologies, Inc. (HSDT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term....

HSDT : 5.74 (-1.03%)
Stereotaxis Inc. (STXS) Reports Q3 Loss, Misses Revenue Estimates

Stereotaxis Inc. (STXS) delivered earnings and revenue surprises of -16.67% and 2.46%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

STXS : 3.05 (+8.54%)
HSDT : 5.74 (-1.03%)
Masimo (MASI) Q3 Earnings and Revenues Surpass Estimates

Masimo (MASI) delivered earnings and revenue surprises of 8.70% and 2.87%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

MASI : 132.21 (+0.92%)
HSDT : 5.74 (-1.03%)
Coverage Initiation With Bullish Price Target Causes Buying Pressure

A Pennsylvania-based healthcare company is seeing a pretty strong rally during Tuesday’s premarket after it was announced that %RothCapital analyst Jonathon Aschoff initiated coverage on the company...

HSDT : 5.74 (-1.03%)
Helius Medical Technologies, Inc. to Release Second Quarter 2022 Financial Results on August 15, 2022

NEWTOWN, Pa., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech...

HSDT : 5.74 (-1.03%)
HSM.TO : 18.35 (-1.71%)
Helius Medical Technologies, Inc. Announces Pricing of $18 Million Public Offering

NEWTOWN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused...

HSDT : 5.74 (-1.03%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Helius Medical Technologies Inc. is a specialty medical device company. It is focused on the development and regulatory approval of its non-invasive neurostimulation device called PoNS. The Company is nearing clinical trials for balance disorders in TBI patients and for the treatment of MS. Helius Medical...

See More

Key Turning Points

3rd Resistance Point 5.98
2nd Resistance Point 5.91
1st Resistance Point 5.83
Last Price 5.74
1st Support Level 5.68
2nd Support Level 5.61
3rd Support Level 5.53

See More

52-Week High 16.25
Fibonacci 61.8% 12.22
Fibonacci 50% 10.97
Fibonacci 38.2% 9.72
Last Price 5.74
52-Week Low 5.69

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar